A biomarker of DUX4 activity to evaluate losmapimod treatment effect in FSHD Phase 2 trialsL. Ronco,K. Wagner,D. Cadavid,A. Chang,M. Mellion,A. Robertson,S. Raines,J. Chadchankar,A. Rojas,P. Shieh,N. Shen,J. Statland,S. Tapscott,R. Tawil,B. van Engelen,L. Wang,N. Johnson,O. WallaceNEUROLOGY（2020）引用 0|浏览42暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
